1.Study on the mechanism of the gut microbiota-short-chain fatty acids axis in lactose intolerance in infants
Yuyin CHANG ; Tailing LU ; Ming LU ; Donglin SHEN
Chongqing Medicine 2025;54(8):1894-1898,1903
Objective To explore the mechanism of the gut microbiota-short-chain fatty acid axis in the heterogeneity of lactose intolerance(LI)in infants.Methods A total of 138 children diagnosed with LI due to diarrhea in the Affiliated Hospital of Xuzhou Medical University from June 2024 to April 2025 were selected as the research subjects.According to the severity of LI,they were divided into the mild LI group(n=68)and the severe LI group(n=70),and then 50 healthy children who received health care during the same period were selected as the healthy control group.The structure of the intestinal flora was analyzed by 16S rRNA gene sequencing,the content of short-chain fatty acids in feces was quantified by gas chromatography-mass spectrometry(GC-MS),and an infant intestinal organoid model was established to verify the functional mech-anism of key short-chain fatty acids.Results Compared with the healthy control group,the Shannon index,the abundance of Bifidobacterium,and the ratio of Bifidobacterium to Escherichia coli abundance(B/E)in the mild LI group and the severe LI group were lower,and the severe LI group was lower than the mild LI group(P<0.05).Compared with the healthy control group,the Escherichia coli/Shigella abundance was higher in the mild LI group and the severe LI group,and the severe LI group was higher than the mild LI group(P<0.05).Compared with the healthy control group,the levels of total short-chain fatty acids,acetic acid,propionic acid and butyric acid in the mild LI group and the severe LI group were lower,and those in the severe LI group were lower than those in the mild LI group(P<0.05).The multiple linear regression predic-tion model showed that the frequency of diarrhea=6.80-0.17×butyric acid+0.25×Escherichia coli-0.31×Bifidobacterium.The area under the curve of the prediction efficacy of this model was 0.89(95%CI:0.83-0.94).Compared with the control intestinal cells,the levels of transepithelial layer resistance(TEER)and tight junction protein(Claudin)-3 in the intestinal cells treated with lactose were lower,and the level of IL-8 was higher.However,the levels of TEER and Claudin-3 in the intestinal cells treated with lactose+bu-tyric acid were higher than those in the intestinal cells treated with lactose,and the level of IL-8 was lower(P<0.05).Conclusion The imbalance of intestinal flora and butyric acid deficiency jointly lead to the differ-ences in LI symptoms in infants and young children.
2.Effect Analysis of Different Courses of Saccharomyces Boulardii Powder on Helicobacter Pylori Eradication in Children
Lulu FANG ; Donglin SHEN ; Yuyin CHANG
Journal of Medical Research 2023;52(11):175-179
Objective To investigate the efficacy of different courses of saccharomyces boulardii powder combined with triple therapy in eradicating helicobacter pylori(Hp)in children.Methods A total of 135 children with Hp-related gastritis who received initial treatment in the Department of Pediatrics,Affiliated Hospital of Xuzhou Medical University from October 2021 to June 2022 were selected and divided into three groups according to random number table method:group A,group B and group C,with 45 cases in each group.Group A:triple therapy(omeprazole + clarithromycin + amoxicillin)for 14 days;group B and group C:on the basis of triple therapy,saccharomyces boulardii powder was added from the first day of treatment for 2 weeks and 4 weeks,respectively.The adverse reactions during treatment were recorded,the levels of serum pepsinogen Ⅰ(PGⅠ)and pepsinogen Ⅱ(PGⅡ),clinical efficacy and Hp eradica-tion rate were observed 4 weeks after the end of treatment.Results The levels of serum PGⅠ and PGⅡ in the three groups after treat-ment were significantly lower than those before treatment(P<0.05),the levels of serum PGⅠ and PGⅡ in group B and group C after treatment were lower than those in group A(P<0.05),and the levels of serum PGⅠ and PGⅡ in group B were lower than those in group C after treatment(P<0.05).The clinical effective rates of group B(93.0%)and group C(90.4%)were higher than those of group A(62.5%)(P<0.05).The clinical effective rate of group B was higher than that of group C(P>0.05).The Hp eradication rate of group B and group C was significantly higher than that of group A(P<0.05),and the Hp eradication rate of group B was higher than that of group C(P>0.05).The incidence of diarrhea and loss of appetite in group B and group C were lower than those in group A(P<0.05);the incidence of diarrhea and loss of appetite in group B was lower than that in group C(P<0.05).There was no signifi-cant difference in the incidence of abdominal pain,nausea and vomiting among the three groups(P>0.05).Conclusion Saccharomy-ces boulardii decoction combined with triple therapy for 2 or 4 weeks can effectively regulate PG level,improve the eradication rate of Hp,and reduce the incidence of adverse reactions.It is suggested that 2 weeks is the best course of treatment.
3.Study on the expression of NLR family,pyrin domain containing 6 in children with chronic non-atrophic gastritis
Siyu GU ; Donglin SHEN ; Ming WU ; Yuyin CHANG ; Jing CHENG
Clinical Medicine of China 2022;38(3):262-267
Objective:To explore the expression of the nucleotide-binding oligomerization domain-like receptor containing pyrin domain protein 6 (NLR family,pyrin domain containing 6,NLRP6) in the gastric tissue and gastric juice of children with chronic non-atrophic gastritis (CNG), and to analyze the influence of Helicobacter pylori (Hp) infection on the expression of NLRP6.Methods:A case-control study was conducted to select 120 CNG patients in pediatrics of Department of Pediatrics, The Affiliated Hospital of Xuzhou Medical University from October 2020 to July 2021. According to pathological diagnosis, endoscopic gastric mucosal damage and Hp infection, they were divided into 4 groups: mild CNG group Hp negative, Moderate to severe CNG group Hp negative, Mild CNG group Hp positive, Moderate to severe CNG group Hp positive. The enzyme-linked immunosorbent assay (ELISA) was used to detect the expression level of NLRP6 in the four groups of gastric tissue and gastric juice, and Western blot was used to detect the expression of NLRP6 in the gastric tissue of the 4 groups, and the significance of expression in CNG of children is analyzed. Independent sample t-test was used to compare the mean between the two groups. One way ANOVA was used to compare the mean of multiple groups of samples, and LSD t-test was used for pairwise comparison. Comparison between count data groups χ 2 inspection. Results:The positive rate of Hp in the moderate to severe chronic non-atrophic gastritis group was 62.96% (34/54) higher than that in the mild chronic non-atrophic gastritis group 37.04% (20/54), and the difference was statistically significant (χ 2=18.32, P<0.001). Under the same Hp conditions, the expression of NLRP6 in the mild chronic non-atrophic gastritis group (Hp negative mild CNG: gastric tissue (653.73±37.71) ng/L, gastric juice (471.75±38.47) ng/L; Hp positive mild CNG: Gastric tissue (616.69±43.33) ng/L, gastric juice (445.29±36.39) ng/L was higher than the moderate to severe chronic non-atrophic gastritis group (Hp negative moderate to severe CNG: gastric tissue (623.82±52.99) ng/L, gastric juice (446.48±47.49) ng/L; Hp positive Moderate to severe CNG: gastric tissue (580.43±62.75) ng/L, gastric juice (406.88±51.85) ng/L, the difference is statistically significant (under Hp negative, mild compared with moderate to severe CNG: gastric tissue P=0.035; gastric juice P=0.046; Under Hp positive, mild compared with moderate to severe CNG: gastric tissue P=0.010;gastric juice P=0.002); in the same degree of gastric mucosal injury, NLRP6 expression in Hp-negative group (Hp-negative mild CNG: gastric tissue (653.73±37.71) ng/L, gastric juice (471.75±38.47) ng/L; Hp negative moderate to severe CNG: gastric tissue (623.82±52.99) ng/L, gastric juice (446.48±47.49) ng/L higher than the positive group (Hp positive mild CNG: gastric tissue (616.69±43.33) ng/L, gastric juice (445.29±36.39) ng/L; Hp positive moderate to severe CNG: gastric tissue (580.43±62.75) ng/L, gastric juice (406.88±51.85) ng/L, the difference is statistically significant (under mild CNG, Hp negative is compared with positive: Gastric tissue P=0.005; gastric juice P=0.023; under moderate to severe CNG, negative versus positive: gastric tissue P=0.004; gastric juice P=0.003). Conclusion:Under the same Hp conditions, the more severe the gastric mucosal damage, the lower the NLRP6; under the same degree of mucosal damage, the expression level of NLRP6 in the Hp-negative group was significantly higher than that of the Hp-positive group. It is suggested that NLRP6 plays a role in inhibiting inflammation in chronic gastritis, maintaining the integrity of epithelial cells, and Hp can inhibit the expression of NLRP6.
4.Expression of bFGF and TGF-β1 in different stages of myocardial ifbrosis
Tailing LU ; Ming LU ; Yuyin CHANG
Journal of Clinical Pediatrics 2016;34(5):371-374
Objective To study the expression of basic ifbroblast grouth factor (bFGF) and transforming growth factorβ1 (TGF-β1) in different stages of myocardial ifbrosis (CFs). Methods CFs of neonatal Sprague-Dawley rats were isolated with the method of trypsin digestion and differential anchoring velocity, then cultured in vitro. The generation 2-4 of CFs were used for the experiment and randomly divided into 2 groups:the control group were cultured without AngII , and the test group were cultured with AngII 10-6 mol/L. The test group were cultured for 12, 24, 48, and 72 h respectively, and then the synthesis of col agen were measured by ELISA, the bFGF, TGF-β1-mRNA expression was measured by RT-PCR, and the bFGF and TGF-β1 protein expression was measured by western blot analyses. Results Compared with those of control group, the expressions of bFGF and TGF-β1 both in gene and in protein in the test groups increased gradual y with the timing (P?0.01). Correlation analysis found that the expression of bFGF mRNA and protein were positively associated with TGF-β1 mRNA and protein (r?=?0.967, 0.947, P?<0?.05), and both bFGF and TGF-β1 were positively associated with the supernatant col agen. (r?=?0.932, 0.881, 0.930, 0.896, P?<0?.05). Conclusion bFGF and TGF-β1 may be involved in the occurrence and development of myocardial ifbrosis.

Result Analysis
Print
Save
E-mail